China Literature Zukünftiges Wachstum

Future Kriterienprüfungen 2/6

China Literature wird ein jährliches Gewinn- und Umsatzwachstum von 15.7% bzw. 6.4% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 16.2% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 6.7% betragen.

Wichtige Informationen

14.9%

Wachstumsrate der Gewinne

14.3%

EPS-Wachstumsrate

Media Gewinnwachstum	16.4%
Wachstumsrate der Einnahmen	4.2%
Zukünftige Eigenkapitalrendite	7.5%
Analystenabdeckung	Good
Zuletzt aktualisiert	20 Aug 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Keine Aktualisierungen

Recent updates

Gewinn- und Umsatzwachstumsprognosen

SHSC:772 - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (CNY Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
12/31/2026	8,563	1,390	1,632	1,608	11
12/31/2025	8,154	1,263	1,492	1,405	14
12/31/2024	7,797	1,088	1,301	1,244	14
6/30/2024	7,920	933	2,002	2,130	N/A
3/31/2024	7,466	869	1,478	1,631	N/A
12/31/2023	7,012	805	954	1,131	N/A
9/30/2023	6,917	781	1,077	1,309	N/A
6/30/2023	6,821	756	1,199	1,486	N/A
3/31/2023	7,224	682	1,226	1,531	N/A
12/31/2022	7,626	608	1,253	1,577	N/A
9/30/2022	8,019	800	1,195	1,486	N/A
6/30/2022	8,413	992	1,137	1,395	N/A
3/31/2022	8,541	1,420	1,075	1,257	N/A
12/31/2021	8,668	1,847	1,013	1,118	N/A
9/30/2021	9,138	871	933	1,059	N/A
6/30/2021	9,608	-105	852	999	N/A
3/31/2021	9,067	-2,295	837	1,055	N/A
12/31/2020	8,526	-4,484	822	1,110	N/A
9/30/2020	8,581	-3,538	950	1,218	N/A
6/30/2020	8,637	-2,593	1,079	1,326	N/A
3/31/2020	8,492	-748	822	1,054	N/A
12/31/2019	8,348	1,096	566	783	N/A
9/30/2019	7,037	947	409	614	N/A
6/30/2019	5,726	798	253	445	N/A
3/31/2019	5,382	854	494	681	N/A
12/31/2018	5,038	911	735	918	N/A
9/30/2018	4,746	880	807	974	N/A
6/30/2018	4,454	850	880	1,031	N/A
3/31/2018	4,274	703	N/A	958	N/A
12/31/2017	4,095	556	N/A	886	N/A
9/30/2017	3,788	402	N/A	721	N/A
6/30/2017	3,481	249	N/A	557	N/A
3/31/2017	3,019	143	N/A	372	N/A
12/31/2016	2,557	37	N/A	186	N/A
12/31/2015	1,607	-348	N/A	198	N/A
12/31/2014	466	-21	N/A	109	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: 772Das prognostizierte Gewinnwachstum (15.7% pro Jahr) liegt über der Sparquote (2.2%).

Ertrag vs. Markt: 772Die Erträge des Unternehmens (15.7% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Hong Kong (12% pro Jahr).

Hohe Wachstumserträge: 772Die Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.

Einnahmen vs. Markt: 772Die Einnahmen des Unternehmens (6.4% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt Hong Kong (7.9% pro Jahr).

Hohe Wachstumseinnahmen: 772Die Einnahmen des Unternehmens (6.4% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: 772Die Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (6.7%).

China Literature Zukünftiges Wachstum

Future Kriterienprüfungen 2/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

First half 2024 earnings released: EPS: CN¥0.50 (vs CN¥0.37 in 1H 2023)

First half 2024 earnings released: EPS: CN¥0.50 (vs CN¥0.37 in 1H 2023)

China Literature Limited to Report First Half, 2024 Results on Aug 12, 2024

Full year 2023 earnings released: EPS: CN¥0.80 (vs CN¥0.60 in FY 2022)

Full year 2023 earnings released: EPS: CN¥0.80 (vs CN¥0.60 in FY 2022)

Investor sentiment improves as stock rises 15%

New minor risk - Share price stability

Investor sentiment improves as stock rises 18%

Investor sentiment deteriorates as stock falls 17%

Non-Executive Chairman of the Board recently bought HK$1m worth of stock

China Literature Limited to Report Fiscal Year 2023 Results on Mar 18, 2024

Investor sentiment improves as stock rises 18%

Investor sentiment improves as stock rises 21%

First half 2023 earnings released: EPS: CN¥0.37 (vs CN¥0.23 in 1H 2022)

China Literature Limited to Report First Half, 2023 Results on Aug 10, 2023

China Literature Limited Announces Board Changes

Non-Executive Chairman of the Board recently bought HK$1.6m worth of stock

Investor sentiment improves as stock rises 21%

China Literature Limited Announces Executive Changes

China Literature Limited Appoints Mr. Xie Qinghua as A Non-Executive Director

China Literature Limited Announces Management Changes

Investor sentiment improves as stock rises 20%

Full year 2022 earnings released: EPS: CN¥0.60 (vs CN¥1.83 in FY 2021)

China Literature Limited to Report Fiscal Year 2022 Results on Mar 16, 2023

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Less than half of directors are independent

Investor sentiment deteriorated over the past week

First half 2022 earnings released: EPS: CN¥0.23 (vs CN¥1.08 in 1H 2021)

China Literature Limited to Report Q2, 2022 Results on Aug 15, 2022

Less than half of directors are independent

Less than half of directors are independent

Non-Executive Director recently bought HK$24m worth of stock

First half 2021 earnings released: EPS CN¥1.08 (vs CN¥3.30 loss in 1H 2020)

Non-Executive Director recently sold HK$5.5m worth of stock

Non-Executive Director recently sold HK$3.7m worth of stock

Vice Chairman Wenhui Wu has left the company

Full year 2020 earnings released: CN¥4.48 loss per share (vs CN¥1.10 profit in FY 2019)

Non-Executive Director recently sold HK$1.9m worth of stock

Full year 2020 earnings released

New 90-day high: HK$85.00

Non-Executive Director recently sold HK$1.6m worth of stock

New 90-day high: HK$64.30

China Literature Limited (SEHK:772), Baidu, Inc. (NasdaqGS:BIDU) and Shenzhen Investment Limited (SEHK:604) signed an agreement to acquire 15% stake in COL Digital Publishing Group Co., Ltd. (SZSE:300364) from its shareholders for approximately CNY 600 million

China Literature Limited to Report Fiscal Year 2020 Results on Mar 23, 2021

New 90-day low: HK$55.45

China Literature Limited Announces Retirement of Zhao Jincheng as Joint Company Secretary

New 90-day high: HK$61.95

CEO & Executive Director recently bought HK$21m worth of stock

First half earnings released

First half earnings released

China Literature Limited to Report First Half, 2020 Results on Aug 11, 2020

Gewinn- und Umsatzwachstumsprognosen

Analystenprognosen zum zukünftigen Wachstum

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Wachstumsunternehmen entdecken